MaaT Pharma To Present and Participate in Investor and Medical Conferences in September Lyon, France,…
MaaT PharmaSeptember 4, 2024
MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the…
MaaT PharmaJuly 5, 2024
MaaT Pharma: Half-year Report and an Increase of the Resources Allocated to the Liquidity Contract…
MaaT PharmaJuly 5, 2024
MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the…
MaaT PharmaJune 10, 2024
MaaT Pharma Presents the Results of its Annual Ordinary and Extraordinary General Meeting Lyon, France,…
MaaT PharmaMay 29, 2024
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION…
MaaT PharmaMay 15, 2024
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION…
MaaT PharmaMay 14, 2024
MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the…
MaaT PharmaMay 6, 2024
MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the…
MaaT PharmaApril 9, 2024
